AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. ABVX
  4. [6-K] Abivax SA American Current Report (Foreign Issuer)

[6-K] Abivax SA American Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source:

Stock ABVX logo
Abivax S.A.

NASDAQ:ABVX

ABVX Rankings

#4521 Ranked by Market Cap
N/A Ranked by Dividends

ABVX Latest News

Jul 25, 2025
Abivax Announces Full Exercise of Underwriters� Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (�637.5M)
Jul 24, 2025
Abivax Announces Pricing of $650M (�554M) Public Offering of American Depositary Shares
Jul 24, 2025
Abivax announces trading resumption of its ordinary shares on Euronext Paris
Jul 24, 2025
Abivax announces temporary trading halt of its ordinary shares on Euronext Paris
Jul 23, 2025
Abivax Announces Launch of Public Offering

ABVX Latest SEC Filings

Jul 24, 2025
[424B5] Abivax SA American Prospectus Supplement (Debt Securities)
Jul 24, 2025
[6-K] Abivax SA American Current Report (Foreign Issuer)
Jul 23, 2025
[424B5] Abivax SA American Prospectus Supplement (Debt Securities)

ABVX Stock Data

4.35B
63.42M
47.53%
1.95%
Biotechnology
Healthcare
France
Paris